This topic contains a solution. Click here to go to the answer

Author Question: The nurse knows that proper placement of the tocotransducer for electronic fetal monitoring is a. ... (Read 79 times)

jasdeep_brar

  • Hero Member
  • *****
  • Posts: 569
The nurse knows that proper placement of the tocotransducer for electronic fetal monitoring is
 
  a. Over the uterine fundus
  b. On the fetal scalp
  c. Inside uterus
  d. Over the mother's lower abdomen

Question 2

The normal female pelvis is termed a ___________________ _ pelvis.
 
  Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bulacsom

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

A
Feedback
A The tocotransducer monitors uterine activity and should be placed over the
fundus, where the most intensive uterine contractions occur.
B The tocotransducer monitors uterine contractions.
C The tocotransducer is for external use.
D The most intensive uterine contractions occur at the fundus; this is the best
placement area.

Answer to Question 2

gynecoid




jasdeep_brar

  • Member
  • Posts: 569
Reply 2 on: Jun 27, 2018
Great answer, keep it coming :)


Jsherida

  • Member
  • Posts: 314
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Oxytocin is recommended only for pregnancies that have a medical reason for inducing labor (such as eclampsia) and is not recommended for elective procedures or for making the birthing process more convenient.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

For a complete list of videos, visit our video library